What is PharmaSecure?
PharmaSecure operates as a specialized provider of supply chain traceability solutions tailored for the pharmaceutical industry. The company offers a comprehensive suite of services, including serialization, track and trace, product authentication, and consumer engagement. With over 15 years of operational history, PharmaSecure has successfully secured more than 6 billion products, integrating its patented technology across hundreds of production lines. By addressing the persistent challenges of counterfeiting and regulatory adherence, the company serves as a vital partner to some of the world's largest pharmaceutical manufacturers, enhancing both operational efficiency and brand loyalty through advanced technological deployment.
How much funding has PharmaSecure raised?
PharmaSecure has raised a total of $3.9M across 1 funding round:
Unspecified
$3.9M
Unspecified (2011): $3.9M with participation from HealthTech Capital, TEEC Angel Fund, Innovation Endeavors, and Gray Ghost Ventures
Key Investors in PharmaSecure
HealthTech Capital
HealthTech Capital is a private investment organization focused on healthtech and digital health startups, providing funding and mentoring since 2010.
TEEC Angel Fund
TEEC Angel Fund is a venture-capital fund established by Silicon Valley entrepreneurs and Tsinghua University alumni, focusing on artificial intelligence and physical systems.
Innovation Endeavors
Innovation Endeavors is an early-stage venture capital firm that invests in visionary founders and transformational technologies, with a focus on life sciences and logistics.
What's next for PharmaSecure?
With the successful completion of this major strategic investment, PharmaSecure is well-positioned to accelerate its growth trajectory within the global life sciences market. The company is expected to focus on expanding its technological footprint, potentially integrating emerging data analytics and advanced computation to further refine its serialization capabilities. As regulatory environments become increasingly stringent, PharmaSecure's ability to provide robust, scalable authentication frameworks will likely drive continued adoption among enterprise-level clients. The firm's focus remains on maintaining its leadership in the pharmaceutical supply chain ecosystem while exploring new avenues for product authentication and consumer-facing engagement tools.
See full PharmaSecure company page
